#United States #Plano #AnX Robotica #MotiliCap #MotiliScan

AnX Robotica Celebrates FDA 510(k) Clearance for MotiliCap and MotiliScan

In a significant advancement for gastrointestinal diagnostics, AnX Robotica has announced that it has received FDA 510(k) clearance for its revolutionary products: MotiliCap and MotiliScan. This pivotal approval marks a noteworthy leap forward in gastrointestinal motility monitoring, promising clinicians the ability to assess gut transit times with unmatched accuracy and ensuring patient comfort through non-invasive procedures.

Overview of MotiliCap™ and MotiliScan™

MotiliCap is a cutting-edge motility capsule conceived to evaluate gastrointestinal transit through the stomach, small intestines, and colon. It is the most comprehensive solution available on the market, effectively replacing the now-discontinued SmartPill technology. The features of MotiliCap include:

• - Radiation-Free and Non-Sedative: Unlike traditional methods that may involve radiation, MotiliCap presents a safe alternative devoid of sedation, enhancing patient experience.
• - Comprehensive Insights: This innovative capsule collects vital data on gastric emptying rates, small bowel movements, and colonic motility, providing detailed insights that are crucial for diagnosis and management of gastrointestinal disorders.

Data collected from MotiliCap is seamlessly integrated into the MotiliScan software, which enables clinicians to visualize fluctuations in pH, pressure, and temperature in real-time. This comprehensive data visualization significantly empowers healthcare professionals to identify motility disorders efficiently.

Excitement from AnX Robotica’s Leadership

The announcement was met with enthusiasm from AnX Robotica’s Vice President of Marketing and Product Management, Stu Wildhorn, who stated, "We are thrilled to receive FDA clearance for MotiliCap and MotiliScan, reinforcing our commitment to bringing innovative, patient-friendly diagnostic tools to patients and our customers." This declaration highlights the company's ongoing commitment to refining and delivering advanced diagnostic solutions to healthcare providers.

Benefits of MotiliScan™ Software

Moreover, the MotiliScan software is designed with usability and efficiency in mind. Its built-in features allow for:

• - Custom Reporting: Tailored reporting options enhance the tool's functionality, helping physicians to document findings efficiently.
• - Segment-Specific Analysis: Clinicians can conduct detailed examinations based on specific segments of the gastrointestinal tract.
• - Automated Summaries: The software compiles comprehensive summaries automatically, streamlining the workflow and aiding in quicker decision-making processes for treatment.

This user-friendly approach ultimately leads to improved clinical workflows and better outcomes for patients, aligning with AnX Robotica's mission of enhancing patient care through innovative technology.

Future of GI Diagnostics

Building on the success of its existing platform, NaviCam®, AnX Robotica is now poised to revolutionize gastrointestinal diagnostics even further with the launch of these new products. The NaviCam suite includes multiple innovative offerings like NaviCam SB with ProScan™, NaviCam Capsule/Tether, and the NaviCam Xpress MCCE System, all designed to elevate the standard of patient care and empower clinicians with actionable insights.

AnX Robotica’s FDA clearance for MotiliCap and MotiliScan not only fills the gap left by SmartPill but enhances the diagnostic capabilities with advanced technology, placing better tools in the hands of healthcare professionals.

For further insights about MotiliCap, MotiliScan, and AnX Robotica's comprehensive range of diagnostic solutions, visit anxrobotica.com.

Note: The Colon Capsule is not available in the United States.